Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
نویسندگان
چکیده
USA 1999;96:12719-24. 16 Bataller R, Brenner D. Hepatic stellate cells as a target for the treatment of liver fibrosis. Seminars in Liver Disease 2001;21:437-51. 17 Benyon RC, Arthur MJP. Extracellular matrix degradation and the role of hepatic stellate cells. Seminars in Liver Disease 2001;21:373-84. 18 Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP. Expression of tissue inhibitor of metalloproteinases-1 and -2 is increased in fibrotic human liver.Gastroenterology 1996;110:821-31. 19 Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-49. 20 Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burkhardt E, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001;35:749-55. 21 Poynard T,McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.Gastroenterology 2002;122:1303-13. 22 Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001;121:685-98. 23 Imuro Y, Nishio T,Morimoto T, Nitta T, Stefanovic B, Choi SK, et al Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.Gastroenterology 2003;124:445-58. 24 Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Seminars in Liver Disease 2002;21:337-49. 25 RosenbergW, Burt A, Becka M,Voelker M,Arthur MJP. Automated assays of serum markers of liver fibrosis predict histological hepatic fibrosis. Hepatology 2000;32:183A. 26 Friedman SL, Arthur MJP. Reversing hepatic fibrosis. Sci Med 2002;8:194-205.
منابع مشابه
Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases
Following the skyrocketing spread of SARS-CoV-2 into almost all the countries over five continents, diverse clinical strategies are urgently needed to defeat its pandemic, considering that an magic-bullet antiviral vaccine or treatment is presently unavailable. WHO later proclaimed the viral outbreak as a pandemic. Despite this fast speed of the pandemic, any recommended treatment must first...
متن کاملThe effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
OBJECTIVES To examine trends and predictors of prescription medications on discharge after first (index) hospitalisation for heart failure (HF), and the effect on all-cause mortality of evidence-based therapy. DESIGN A retrospective multicentre cohort study, with medical record review. SETTING Three tertiary-care hospitals in Perth, Western Australia. PATIENTS WA Hospital Morbidity Data w...
متن کاملUse, tolerability and compliance of spironolactone in the treatment of heart failure
BACKGROUND Risk of morbidity and mortality in patients with severe heart failure (HF) is reduced by blockade of aldosterone receptors with spironolactone. However, benefits of spironolactone are potentially limited by treatment compliance and adverse events profile. The aim of this study was to estimate use of spironolactone by patients with HF, incidence of key adverse events, and patient comp...
متن کاملUpdate of treatment of heart failure with reduction of left ventricular ejection fraction
Underlying and precipitating causes of heart failure (HF) with reduced left ventricular ejection fraction (HFrEF) should be identified and treated when possible. Hypertension should be treated with diuretics, angiotensin-converting enzyme (ACE) inhibitors, and β-blockers. Diuretics are the first-line drugs in the treatment of patients with HFrEF and volume overload. Angiotensin-converting enzym...
متن کاملNew modalities for treatment of diabetic nephropathy: a mini review
Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...
متن کاملManagement of hyperkalaemia in adults.
The reported incidence of hyperkalaemia in hospitalisedpatients is between 1 and 10%. I Thevast majority of cases are related to patients prescribed angiotensin converting enzyme inhibitors (ACE) or angiotensin II receptor blockers (ARBs) in conjunction with spironolactone with pre-existing or new renal failure. Most other cases are related to potassium supplementation and prescription of diure...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 327 7407 شماره
صفحات -
تاریخ انتشار 2003